Sankyo Company, Limited

Nec Solution Innovators, Ltd.

Temco Japan Co., Ltd.

Nec Corporation

University of California

Renascience Co., Ltd.

Nec Solution Innovations, Ltd.

Hiroaki Yanagisawa

Toshihiko Fujiwara

Koichi Fujimoto

Takashi Fujita

Takao Yoshioka

Hiroyoshi Horikoshi

Kunio Wada

Minoru Oguchi

Hiroyuki Koike

Hideo Nakao

Akiko Ando

Takuro Kanazaki

Koji Morishita

Hisashi Noda

Yasuo Shimoji

Yoshiya Amemiya

Masami Fukushima

Masakatsu Kaneko

Sadao Ishihara

Toshio Sada

Bunji Shimizu

Yasuteru Iijima

Shinichi Sugawara

Mitsuo Nagano

Makoto Takamura

Akio Saito

Toshio Miyata

Yoshio Tsujita

Yousuke Motohashi

Takashi Nonaka

Hiroshi Nishino

C Anthony Hunt

Tomihisa Yokoyama

Shouji Fujino

Martin A Apple

Jiro Nawa

Kazuji Kobayashi

Mitsuya Sakurai

Kiyoshi Kurokawa

Tsunemichi Hosokawa

Mayo Taketa

A display control device includes a first display control unit performing control so as to display a page, which is being displayed in a real space, in a first material as a presentation material used in a presentation by a presenter in a first position in a virtual reality space, a second display control unit performing control so as to display a second material in a second position which is different from the first position in the virtual reality space, and an operation input information acquisition unit acquiring first operation input information as operation input information which is input by a viewer experiencing the virtual reality space and which is about display of the second material, in which the second display control unit changes a display manner of the second material based on the first operation input information.

Display control device, display control method, and non-transitory computer-readable medium storing program

The present invention provides a new system that allows an easier operation of a moving object. The present invention provides a moving object operation system including: a moving object; and an operation signal transmitter. The moving object includes a signal receipt unit that receives an operation signal. The transmitter includes: an auxiliary tool; a storage unit that contains conversion information; a movement information acquisition unit that acquires auxiliary tool movement information; a conversion unit that converts the acquired movement information into the operation signal based on the conversion information; and a signal transmission unit that transmits the operation signal. The conversion information includes auxiliary tool movement information and operation signal information for instructing the moving object in how to move, and those are associated with each other. The movement information associated with human motion is auxiliary tool movement information associated with human motion imagining movement of the moving object.

Moving object operation system, operation signal transmission system, moving object operation method, program, and recording medium

The present invention provides a new system that allows an easier operation of a moving object. The present invention provides a moving object operation system () including a moving object () and an operation signal transmitter () for the moving object (). The moving object () includes a signal receipt unit () that receives an operation signal from the operation signal transmitter (). The operation signal transmitter () includes a storage unit () that contains conversion information, a motion information acquisition unit () that acquires motion information of an operator, a conversion unit () that converts the acquired motion information into the operation signal to the moving object () based on the conversion information, and a signal transmission unit () that transmits the operation signal to the moving object ().

A drone maneuvering system includes a drone and a maneuvering signal transmitter set. The maneuvering signal transmitter set includes a first transmitter that controls at least forward, reverse, left, and right movement of the drone, and a second transmitter that controls vertical movement and rotational movement of the drone. The first transmitter includes a first auxiliary tool and transmits to the drone a maneuvering signal including tilt information of the first auxiliary tool that accompanies the actions of a pilot, in which the forward, reverse, left, and right movements of the drone are imaged. The second transmitter includes a second auxiliary tool and transmits to the drone a maneuvering signal including rotation information of the second auxiliary tool that accompanies the actions of the pilot, in which the vertical movements and rotational movements of the drone are imaged. The drone operates in accordance with the received maneuvering signals.

Drone maneuvering system, maneuvering signal transmitter set, and drone maneuvering method

The present invention provides a new system that allows a safer operation of a moving object. The present invention provides a moving object operation system () including: a moving object (); a plurality of operation signal transmitters (A,B) for the moving object; and a synchronization unit (). The moving object () includes: a signal receipt unit () that receives operation signals from the operation signal transmitters (A,B). The operation signal transmitters (A,B) include signal transmission units (A,B) that transmit the operation signals to the moving object (), respectively. The synchronization unit () is a unit that synchronizes the operation signal transmitters (A,B).

The present invention provides a compound represented by the following formula (I) wherein A is a cyclic group etc., B is a 1H-tetrazol-5-yl group or a 2,4-dioxothiazolidin-5-yl group, and Y is a single bond or a C6-10 arylene group, or a pharmacologically acceptable salt thereof or an ester thereof.

Phenylene derivative having tetrazole ring or thiazolidinedione ring

Amidocarboxylic acid derivatives

The apparatus eliminates howls to permit a received sound to increase in sound volume to enable the apparatus to be used in high-noise areas, and comprises: a transceived sound volume control circuit,for controlling in sound volume a transceived sound, the circuit,being interposed between: an ear microphone,containing a microphone,and a speaker,and, a communication system,such as PHS. The circuit,comprises: a communication switching means,for performing a switching operation in communications; high-frequency-signal cutting means,which attenuate a received sound signal in a transmission mode and then cut a high-frequency component of the signal; and, a transmitted-sound-signal attenuating means,for attenuating a transmitted-sound signal in a reception mode. The apparatus comprises a means,for cutting energy in the vicinity of a resonance point of the microphone,and a means,for detecting energy in the vicinity of the first formant of a sound to prevent the switching operation from being initiated due to extraneous noises.

Simultaneous two-way communication apparatus using ear microphone

In the apparatus, in accordance with the presence or absence of a barrier, arrangement of its light-receiving and its light-emitting element is changed to avoid interference with its proper light-receiving operation from the barrier, which makesso the apparatus free from noise problems, malfunctions and like troubles caused by the interference. In construction, a cover,permeable to infrared is rotatably mounted on a base,A stationary base plate,and a movable base plate,which is rotatable together with the cover,are stacked together inside the cover,to realize a two-layer arrangement. Each of these base plates,carries a light-receiving element,and/or a light-emitting element,and assumes a substantially semicircular shape.

Infrared transceiving apparatus

Compound of formula (I): ##STR1## [wherein: X represents an unsubstituted or substituted indolyl, indolinyl, azaindolyl, azaindolinyl, imidazopyridyl or imidazopyrimidinyl group; Y represents an oxygen or sulphur atom; Z represents a 2,4-dioxothiazolidin-5-ylidenylmethyl, 2,4-dioxothiazolidin-5-ylmethyl, 2,4-dioxooxazolidin-5-ylmethyl, 3,5-dioxooxadiazolidin-2-ylmethyl or N-hydroxyureidomethyl group; R represents a hydrogen atom, an alkyl group, an alkoxy group, a halogen atom, a hydroxy group, a nitro group, an aralkyl group or a unsubstituted or substituted amino group; and m is an integer of from 1 to 5] have hypoglycemic and anti-diabetic activities.

Heterocyclic compounds having anti-diabetic activity and their use

Phenylalkylcarboxylic acid compounds of the formula: ##STR1## wherein R.sup.1 represents an alkyl group and the like, R.sup.2 represents an alkylene group, R.sup.3 represents a hydrogen atom and the like, X represents a substituted or unsubstituted aryl group and the like, Y represents an oxygen atom and the like, Z represents an alkylene group and the like, and W represents an alkyl group and the like), the pharmacologically acceptable salts thereof or the pharmacologically acceptable esters thereof are useful as therapeutic or preventive agents for hyperglycemia and the like.

Phenylalkylcarboxylic acid compounds and compositions for treating

Compounds of formula (I): ##STR1## [wherein: X represents an unsubstituted or substituted indolyl, indolinyl, azaindolyl, azaindolinyl, imidazopyridyl or imidazopyrinidinyl group; Y represents an oxygen or sulfur atom; Z represents a 2,4-dioxo-thiazolidin-5-ylidenylmethyl, 2,4-dioxothiazolidin-5-ylmethyl, 2,4-dioxooxazolidin-5-ylmethyl, 3,5-dioxo-oxadiazolidin-2-ylmethyl or N-hydroxyureidom ethyl group; R represents a hydrogen atom, an alkyl group, an alkoxy group, a halogen atom, a hydroxy group, a nitro group, an aralkyl group or a unsubstituted or substituted amino group; and m is an inzeger of from 1 to 5] have hypoglycemic and anti-diabetic activities.

Heterocyclic compound having anti-diabetic activity

Compounds of formula (I): ##STR1## wherein: R.sup.1 is hydrogen or alkyl; R.sup.2 is alkylene; R.sup.3 is hydrogen, alkyl, alkoxy, alkylthio, halogen, nitro group, amino group, monoalkylamino, dialkylamino, aryl, or aralkyl; X is aryl, or aromatic heterocyclic; Y is oxygen, sulfur or a group of formula &gt;N--R.sup.4, in which R.sup.4 is hydrogen, alkyl or acyl; and Z is a group of formula (Za), (Zb), (Zc) or (Zd): ##STR2## and salts thereof can be used to treat or prevent are included those arising from hyperlipidemia, hyperglycemia, obesity, impaired glucose tolerance (IGT), insulin resistant non-IGT (NGT), non-diagnostic glucose tolerance, insulin resistance, diabetic complications, fatty liver, polycystic ovary syndrome (PCOS) and gestational diabetes mellitus (GDM); in addition the compounds of the present invention have aldose reductase inhibitory activity.

Oxime derivatives, their preparation and their therapeutic use

Compounds of formula (I): ##STR1## �wherein: X represents an unsubstituted or substituted indolyl, indolinyl, azaindolyl, azaindolinyl, imidazopyridyl or imidazopyrimidinyl group; Y represents an oxygen or sulfur atom; Z represents a 2,4-dioxo-thiazolidin-5-ylidenylmethyl, 2,4-dioxothiazolidin-5-ylmethyl, 2,4-dioxooxazolidin-5-ylmethyl, 3,5-dioxo-oxadiazolidin-2-ylmethyl or N-hydroxyureidomethyl group; R represents a hydrogen atom, an alkyl group, an alkoxy group, a halogen atom, a hydroxy group, a nitro group, an aralkyl group or a unsubstituted or substituted amino group; and m is an integer of from 1 to 5! have hypoglycemic and anti-diabetic activities.

A method of treating ocular hypertension and/or glaucoma in a mammal by locally administering to the eyes of a mammal a composition comprising an effective amount of a compound of the formula wherein R.sup.1 is lower alkyl, lower alkenyl, or R.sup.5 --A--B--, where R.sup.5 is hydrogen, lower alkyl, cycloalkyl or aliphatic acyl; A is oxygen or sulfur; and B is a single bond or a lower alkylene; R.sup.2 is lower alkyl, lower alkenyl, or --C(R.sup.6)(R.sup.7)(R.sup.8), wherein R.sup.6 is hydroxyl or lower alkoxy; and R.sup.7 and R.sup.8 each is hydrogen, lower alkyl, lower alkenyl, lower alkynyl, cycloalkyl, aryl or aralkyl; R.sup.3 is carboxyl or --CON(R.sup.9)(R.sup.10), wherein R.sup.9 and R.sup.10 each is hydrogen or lower alkyl; R.sup.4 is carboxyl, carboxycarbonyl or tetrazol-5-yl; or a pharmacologically acceptable salt or ester thereof.

Method for treating ocular hypertension and glaucoma

Growing community of inventors

Tokyo, Japan

Hiroaki Yanagisawa